Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-Blinded, Placebo-Controlled Cross-Over Study.

Trial Profile

Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-Blinded, Placebo-Controlled Cross-Over Study.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Vulvodynia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2013 Planned end date changed from 1 Jun 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Planned end date changed from 1 Apr 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top